The Magazine for Sleep Professionals
Monday, April 20, 2026
With independent studies showing that 8 out of 10 people use their inhalers incorrectly1, inhaler technique training supports more accurate drug delivery, helping patients get the full benefit of their medication, and resulting in better disease management. The Vitalograph AIM™ (Aerosol Inhalation Monitor) is designed to assist medical practitioners in […]
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of Inhaler Tales – a national campaign aimed at raising awareness about the role inhaler misuse may play in inadequate disease control.1 Central to the campaign is an animated inhaler voiced by actress, producer, and entrepreneur Sarah […]
GlaxoSmithKline plc and Innoviva, Inc. announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to its current license for use in patients with chronic obstructive pulmonary disease […]
Circassia Pharmaceuticals Inc. announced the launch of DUAKLIR® PRESSAIR® (aclidinium bromide and formoterol fumarate) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).1 DUAKLIR will be available in the United States on October 21st and promoted through its dedicated COPD sales force, alongside established COPD treatment TUDORZA® (aclidinium), which […]
Teva Pharmaceutical Industries Ltd. announced that the FDA has approved ProAir® Digihaler™ (albuterol sulfate 117 mcg) inhalation powder, the first and only digital inhaler with built-in sensors which connects to a companion mobile application and provides inhaler use information to people with asthma and COPD. ProAir® Digihaler™ is indicated for the treatment […]
Many asthma patients are prescribed oral corticosteroids (OCS) to treat moderate-to-severe flares and decrease the risk of emergency department (ED) visits or hospitalizations, but with chronic use comes the potential for serious health risks. Allergy & Asthma Network is partnering with allergy and asthma patient advocacy groups, medical professional societies […]
New research from Propeller Health, a digital therapeutics company, suggests that clinical guidelines for assessing asthma control may need to be updated to reflect objective patient information obtained from digital medicines. Propeller’s digital medicine platform helps patients manage diseases like asthma and COPD by delivering concrete insights on symptoms, triggers, […]
